Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Fundus Images

计划入组 531 人 · 首次发布于 2020 年 11 月 3 日

Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Funduscopic Images

计划入组 363 人 · 首次发布于 2023 年 5 月 15 日

Efficacy and Safety of AEYE Diagnostic Screening (AEYE-DS) Software Device for Detection of Diabetic Retinopathy From Digital Funduscopic Images

计划入组 601 人 · 首次发布于 2024 年 2 月 5 日

DS-2243a

DS-2330

DS-7830A

DS BIOPHARMA LIMITED

Ireland

Aeye Health, Inc.

United States

DIPAN SHAH

Australia

AI-Powered Diabetic Retinopathy Screening Achieves 99% Accuracy and Expands to Pharmacy Networks

Daiichi Sankyo's DS-9606 Shows Promise in Phase I Trial for Advanced Solid Tumors

Daiichi Sankyo Discontinues Claudin-6 ADC DS-9606 Following Strategic Portfolio Review